SNHG1 in esophageal cancer promotes cell proliferation and EMT (epithelial to mesenchymal transition)-mediated invasion (56), by down-regulation E-CAD (E-cadherin) and up-regulation VIM (Vimentin) and N-CAD, as well as activation of Notch signaling pathway (57). Here, VIM is linked to esophageal cancer.